Huge News for $ANIX Anixa Biosciences and OntoChem
Post# of 103015
SAN JOSE, Calif., May 4, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that it, with partner OntoChem GmbH, has identified its first therapeutic candidate against Covid-19, and has advanced the compound into biological testing.
https://finance.yahoo.com/news/anixa-bioscien...00443.html